From Medscape Oncology

Coverage from the

Genitourinary Cancers Symposium (GUCS) 2025

February 13 - 15, 2025; San Francisco, California

February 13 - 15, 2025 San Francisco, California

Conference News

GUCS 2025 Nivolumab Bests Placebo in MIBC
Medscape Medical News, February 21, 2025
GUCS 2025 Diet Changes Show Promise in Early Prostate Cancer
Medscape Medical News, February 20, 2025
GUCS 2025 Estradiol Patches Safe, Effective in Prostate Cancer
Medscape Medical News, February 20, 2025
GUCS 2025 EV+P Benefit Continues in Metastatic Urothelial Cancer
Medscape Medical News, February 20, 2025

GUCS 2025 Gene Panel Predicts Radiation Response in Prostate Cancer
Medscape Medical News, February 19, 2025
GUCS 2025 Talazoparib Combo Prolongs Survival in Mets Prostate Cancer
Medscape Medical News, February 14, 2025
GUCS 2025 ‘Man Van’ Diagnoses Nonmetastatic Prostate Cancers
Medscape Medical News, February 14, 2025

Medscape Oncology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Popular News From GUCS 2024

New Guidelines: Start PSA Screening Earlier in Black Men Starting PSA screening in Black men earlier would reduce prostate cancer deaths by about 30%.
Medscape Medical News, Jan 29, 2024
Higher-Dose RT Extends Survival in High-Risk Prostate Cancer Adding higher dose radiation led to long-term ADT led to better progression-free, cancer-specific, and overall survival vs standard-dose radiation in men with high-risk prostate cancer.
Medscape Medical News, Jan 26, 2024

Previous Coverage

All material on this website is protected by copyright, Copyright © 1994-2025 by WebMD LLC. This website also contains material copyrighted by 3rd parties.